Blood Cancer United Inc

Analysis

Blood Cancer United Inc is a registered charity in United States, based in Washington, DC. It received its IRS tax-exemption ruling in January 2001, 25 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Blood Cancer United Inc reported income of $378.3m and spending of $386.1m, spending 102% of its income. Across the 5 years on record, from June 2019 to June 2023, income fell from $396.2m to $378.3m (-4.5%), an average of -1.1% a year. The sharpest change came in the year to June 2020, when income rose by 25%. Over the whole period it spent 93% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Blood Cancer United Inc sits at the 98th percentile: it is larger than about 98% of them. Against every charity in United States with reported income it ranks in the 100th percentile, and in the 100th percentile within DC. Charities of a similar size with the same main cause include Planned Parenthood Federation of ($378.2m), Henry Ford Health Genesys Hospital ($378.8m) and Ascension Ne Wisconsin Inc ($377.9m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 95% and program service revenue 2.5% of the total. Compensation of current officers, directors and key employees was $2.7m (0.7% of expenses). Other salaries and wages came to $93.0m. It paid $4.9m in professional fundraising fees. At year end it held assets of $643.9m against liabilities of $271.3m, net assets of $372.6m. It reported 1,181 employees.